NFKB1 and type 2 diabetes mellitus: NF-κB activation and subsequent nitric oxide (NO) production by inducible nitric oxide synthase (iNOS) have been implicated in β-cell damage and death in both type 1 and type 2 diabetes [7], [8], [9].